A nephrologist argues that advancing kidney care in the US requires tailored guidelines addressing ethnic diversity & fragmented healthcare.

Adding pembrolizumab to docetaxel did not significantly improve outcomes in previously treated patients with mCRPC.

Even among patients with prostate cancer liver metastasis who have a poor prognosis, elevated ctDNA fraction and tumor suppressor gene loss differentiate survival.

Compared to the general population, individuals with incident hospital-based cannabis use disorder care have an increased risk of death.

In-hospital mortality in patients with AMI can be predicted with a risk-standardized model that includes patient factors, such as age and cardiogenic shock.

Physicians should counsel patients considering whether to start treatment for chronic noncancer pain about benefits and harms of cannabis or cannabinoids.

Reducing the infusion time for nivolumab and pembrolizumab to 10 minutes is feasible and safe, according to researchers.

The FDA has granted Priority Review to pegcetacoplan for the treatment of C3 glomerulopathy and primary immune complex membranoproliferative glomerulonephritis.

Patients with solid tumor malignancies had better survival after ICI therapy if they were obese than if they had a normal BMI.

The choice of iron preparation in children with iron-deficiency anemia related to chronic kidney disease (CKD) includes tolerance and response.

“AI can enhance clinical decision-making for common acute symptoms in a virtual urgent care setting,” the authors write. “Thoughtful integration of AI into clinical practice, combining its strengths ...

GLP-1 receptor agonist prescriptions increased significantly during study period across all categories of BMI, in dose-response manner.